Granulocyte-Colony Stimulating Factor, Granulocyte-Macrophage Colony Stimulating Factor, PIXY-321, Stem Cell Factor, Interleukin-3, and Interleukin-7: Receptor Binding and Effects on Clonogenic Proliferation in Acute Lymphoblastic Leukemia

References

• Metcalf D. The molecular control of cell division, differentiation commitment and maturation in hematopoietic cells. Nature 1990; 399: 27–30
   Google Scholar
• Sobol R. E., Mick R., Royston I., Davey F. R., Ellison R. R., Newman R., Cuttner J., Collins J. D., Griffin H., Nelson D. A., Bloomfield C. D. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. N. Engl. J. Med. 1987; 316: 1111–1117
   PubMed Web of Science ®Google Scholar
• Wiersma S. R., Ortega J., Sobel E., Weinberg K. I. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood. N. Engl. J. Med. 1991; 324: 800–808
   PubMed Web of Science ®Google Scholar
• Nishii K., Kita K., Miwa H., Kawakami K., Nakase K., Masuya M., Morita N., Omay S. B., Otsuji N., Fuku-moto M., Shirakawa S. C-kit expression in CD7-positive acute lymphoblastic leukemia: close correlation with expression of myeloid-associated antigen CDI3. Leukemia 1992; 6: 662–668
   PubMed Web of Science ®Google Scholar
• Umiel T., Pattengale P., Weinberg K. I. Simultaneous expression of IL-7 receptor (IL7R) and c-kit mRNA in myeloid antigen-positive (MY +) B-lineage ALL. Blood 1991; 78: 271 a
   Google Scholar
• Shimoda K., Okamura S., Harada N., Ikematsu W., Kondo S., Kawasaki C., Tanaka T., Etou T., Akashi K., Okamura T., Shibuya T., Harada M., Niho Y. Granulocyte colony-stimulating factor receptors on human acute leukemia: biphenotypic leukemic cells possess granulocyte colony-stimulating factor receptors. Cancer Res. 1992; 52: 3052–3055
   PubMed Web of Science ®Google Scholar
• Gattei V., Attadia V., Marotta G., Zagonei V., Canale V., Pinto A. Human granulocyte-macrophage colony stimulating factor (GM-CSF) supports the clonogenic growth of B-lineage acute lymphoblastic leukemias (ALLs) coexpressing myeloid antigens. Proc. ASCO 1992; II: 262
   Google Scholar
• Ohyashiki J. H., Ohyashiki K., Miyauchi J., Fulieda H., Tauchi T., Saito M., Nakazawa S., Kimura N., Clark S. C., Toyama K. Immunogenotypes and clonal culture analysis in B-precursor acute lymphoblastic leukemia. Leukemia 1992; 6: 240–245
   PubMed Web of Science ®Google Scholar
• Makrynikola V., Kabral A., Bradstock K. F. Effects of recombinant human cytokines on precursor-B acute lymphoblastic cells. Exp. Hematal. 1991; 19: 674–679
   PubMed Web of Science ®Google Scholar
• Park L. S., Waldron P. E., Friend D., Sassenfeld H. M., Price V., Anderson D., Cosman D., Andrews R. G., Bernstein I. D., Urdal D. L. Interleukin-3, GM-CSF, and G-CSF receptor expression on cell lines and primary leukemia cells: receptor heterogeneity and relationship to growth factor responsiveness. Blood 1989; 74: 56–65
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Gesner T. G., Song C. W., Myers D. E., Mufson A. Leukemic B-cell precursors express functional receptors for human interleukin-3. Blood 1989; 73: 533–542
   PubMed Web of Science ®Google Scholar
• Wormann B., Gesner T. G., Mufson R. A., LeBien T. W. Proliferative effect of interleukin-3 on normal and leukemic human B cell precursors. Leukemia 1989; 3: 399–404
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H., Sultan C. Proposals for the classification of the acute leukaemias: French-American-British (FAB) cooperative group. Br. J. Haematol. 1976; 33: 451–458
   PubMed Web of Science ®Google Scholar
• Wognum A. W., van Gils F. C. J.M., Wagemaker G. Flow cytometric detection of receptors for interleukin-6 on bone marrow and peripheral blood cells of humans and rhesus monkeys. Blood 1993; 81: 2036–2043
   PubMed Web of Science ®Google Scholar
• Clayberger C., Pillai J. E., Luna-Fineman, Lee A., Campbell M., Levy R., Krensky A. M. Interleukin 3 is a growth factor for human follicular B cell lymphoma. J. Exp. Med. 1992; 175: 371–376
   PubMed Web of Science ®Google Scholar
• Trentin L., Zambello R., Agostini C., Siviero F., Adami F., Marcolongo R., Raimondi R., Chisesi T., Pizzolo G., Semenzato G. Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders. Blood 1993; 81: 752–758
   PubMed Web of Science ®Google Scholar
• Brown R. D., Gorenc B., Gibson J., Warburton P., Joshua D. Interleukin 4 and 6 receptor expression on B cell lines and the lymphocytes of patients with B cell malignancies. Leukemia and Lymphoma 1992; 6: 377–385
   Web of Science ®Google Scholar
• Koistinen P., Wang C., Yang G. S., Wang Y.-F., Williams D. E., Lyman S. D., Minden M. D., McCulloch E. A. OCI/AML4 acute myeloblasts leukemia cell line: regulation and response to cytosine arabinoside. Leukemia 1991; 5: 704–711
   PubMed Web of Science ®Google Scholar
• Young I. T. Proof without prejudice: use of the Kol-mogorov-Smimov test for the analysis of histograms from flow systems and other sources. J. Histochem. Cytochem. 1987; 25: 935–941
   Google Scholar
• Chomcyznski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Ratajczak M. Z., Luger S. M., DeRiel K., Abrahm J., Calabretta B., Gewirtz A. M. Role of the KIT protooncogene in normal and malignant human hemato-poiesis. Proc. Natl. Acad. Set. USA 1992; 89: 1710–1714
   PubMed Web of Science ®Google Scholar
• Ashman L. K., Cambareri A. C., To L. B, Levinsky R. J., Juttner C. A. Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. Blood 1991; 78: 30–37
   PubMed Web of Science ®Google Scholar
• Andre C., D'Auriol Luc, Lacombe C., Gisselbrecht S., Galibert F. c-kit mRNA expression in human and murine hematopoietic cell lines. Oncogene 1989; 4: 1047–1049
   PubMed Web of Science ®Google Scholar
• Estrov Z., Freedman M. H. Growth requirements for human acute lymphoblastic leukemia cells: refinement of a clonogenic assay. Cancer Res. 1988; 48: 5901–5907
   PubMed Web of Science ®Google Scholar
• Estrov Z., Grunberger T., Dube I. D., Wang Y.-P., Freedman M. H. Detection of residual acute lymphoblastic leukemia in cultures of bone marrow obtained during remission. N. Engl. J. Med. 1986; 315: 538–542
   PubMed Web of Science ®Google Scholar
• Re G. G., Estrov Z., Antoun G. R., Felix E. A., Pinkel D. P., Zipf T. F. Differentiation in B-precursor acute lymphoblastic leukemia cell populations with CD34-positive subpopulations. Blood 1991; 78: 575–580
   PubMed Web of Science ®Google Scholar
• Drach D., Zhao S., Drach J., Mahadevia R., Gattringer C., Huber H., Andreeff M. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug-resistant phenotype. Blood 1992; 80: 2729–2734
   PubMed Web of Science ®Google Scholar
• Touw I., Pouwels K., Van Agthoven T., Van Gurp R., Budel L., Hoggerbrugge H., Delwel R., Goodwin R., Na-men A., Lowenberg B. Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia. Blood 1990; 75: 2097–2101
   PubMed Web of Science ®Google Scholar
• Kincade P. W. The lymphopoietic microenvironment in bone marrow. Adv. Cancer Res. 1990; 54: 235
   PubMedGoogle Scholar
• Ryan D. H., Nuccie B. L., Abboud C. N., Winslow J. M. Vascular cell adhesion molecule-1 and the in-tegrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells. J. Clin. Invest. 1991; 88: 995–1004
   PubMed Web of Science ®Google Scholar
• Lemoine F. M., Dedhar S., Lima G. M., Eaves C. J. Transformation-associated alterations in interactions between pre-B cells and fibronectin. Blood 1990; 76: 2311–2320
   PubMed Web of Science ®Google Scholar
• Rennick D., Jackson J., Moulds C., Lee F., Yang G. IL-3 and stromal-derived factor synergistically stimulate the growth of pre-B cell lines cloned from long-term lymphoid bone marrow cultures. J. Immunol. 1990; 142: 161–166
   Web of Science ®Google Scholar
• Freedman M. H., Grunberger T., Correa P., Axelrad A. A., Dube I. D., Cohen A. Autocrine and paracrine growth control by granulocyte monocyte-colony stimulating factor of acute lymphoblastic leukemia cells. Blood 1993; 81: 3068–3075
   PubMed Web of Science ®Google Scholar
• Komada Y., Zhou Y.-W., Zhang S.-L., Azuma E., Sakurai M. Role in growth regulation of cytokines and cytokine receptors in acute lymphoblastic leukaemia expressing myeloid markers. Br. J. Haematol. 1993; 84: 408–415
   PubMed Web of Science ®Google Scholar
• Ferrari S., Grande A., Manfredini R., Tagliafico E., Zucchini P., Torelli G., Torelli U. Expression of interleukins 1, 3, 6, stem cell factor and their receptors in acute leukemia blast cells and in normal peripheral lymphocytes and monocytes. Eur. J. Haematol. 1993; SO: 141–148
   Google Scholar
• Kita K., Nishii K., Ohishi K., Morita N., Takakura N., Kawakami K., Miwa H., Shirakawa S. Frequent gene expression of granulocyte colony-stimulating factor (G-CSF) receptor in CD7+ surface CD3- acute lymphoblastic leukaemia. Leukemia 1993; 7: 1184–1190
   PubMed Web of Science ®Google Scholar
• Eder M., Ottmann O. G., Hansen-Hagge T. E., Bartram C. R., Falk S., Gillis S., Holzer D., Ganser A. In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3, interleukin-7, and accessory cells. Blood 1992; 79: 3274–3284
   PubMed Web of Science ®Google Scholar
• Touw I., Groot-Loonen J., Broeders L., Van Agthoven T., Haehlen K., Hagemeijer A., Lowenberg B. Recombinant hematopoietic growth factors fail to induce a proliferative response in precursor B acute lymphoblastic leukemia. Leukemia 1989; 3: 356–362
   PubMed Web of Science ®Google Scholar
• Ode D. L., Zhou M., Findley H. W., Abdel-Mageed A., Abdelsalam H. R. The effect of recombinant GM-CSF and G-CSF on the bone marrow cells of children with acute lymphoblastic leukemia. Leukemia 1992; 6: 1210–1212
   PubMed Web of Science ®Google Scholar
• Andreeff M., Tafuri A., Hegewisch-Becker S. Colony-stimulating factors (rhG-CSF, rhGM-CSF, rhIL-3, and BCGF) recruit myeloblastic and lymphoblastic leukemic cells and enhance cytotoxic effects of cytosine-arabinoside. Haematology and Blood Transfusion: Acute Leukemias II, Schellong Buechner, Hiddemann, Ritter. Springer Verlag, Berlin-Heidelberg 1990; vol. 33: 747–753
   Google Scholar
• Estrov Z., Ouspenskaja M. V., Lee M. S., Lockhart S. K., McClain K., Pinkel D. P., Felix E. A., Dianov C. M., Zipf T. F. Detection of residual acute lymphoblastic leukemia (ALL) progenitor cells during remission using a clonogenic assay and polymerase chain reaction (PCR). Blood 1992; 80: 258a
   Google Scholar
• Kantarjian H. M., Estey E. H., O'Brien S., Anaissie E., Beran M., Rios M. B., Keating M. J., Gutterman J. Intensive chemotherapy with mitoxantrone and high-dose cytosine arabinoside followed by granulocyte-macrophage colony-stimulating factor in the treatment of patients with acute lymphocytic leukemia. Blood 1992; 79: 876–881
   PubMed Web of Science ®Google Scholar
• Kantarjian H., Estey E., O'Brien S., Robertson L. B., Beran M., Pierce S., Keating M. Granulocyte-colony stimulating factor (G-CSF) supportive care following intensive chemotherapy consolidation in acute lymphoblastic leukemia (ALL) in first remission. Blood 1992; 80: 112a
   Google Scholar
• Ohno R., Tomonaga M., Kobayashi T., Kanamuru A., Shirakawa S., Masaoka T., Omine M., Oh H., Nomura T., Sakai Y., Hirano M., Yokomaku S., Nakayama S., Yoshida Y., Miura A. B., Morishima Y., Dohy H., Niho Y., Hamajima N., Takaku F. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. N. Engl. J. Med. 1990; 323: 871–877
   PubMed Web of Science ®Google Scholar
• Scherrer R., Geissler K., Kyrle P. A., Gisslinger H., Jager U., Bettelheim P., Laczika K., Locker G., Scholten C., Sillaber C., Schwarzinger I., Thalhammer F., Lechner K. Granulocyte colony-stimulating factor (G-CSF) as an adjunct to induction chemotherapy of adult lymphoblastic leukemia (ALL). Ann. Hematol. 1993; 66: 283–289
   PubMed Web of Science ®Google Scholar
• Ottmann O. G., Ganser A., Freund M., Heil G., Hiddemann W., Heit W., Gracien E., Hoelzer D. Simultaneous administration of granulocyte colony-stimulating factor (Filgrastim) and induction chemotherapy in acute lymphoblastic leukemia. Ann. Hematol. 1993; 67: 161–167
   PubMed Web of Science ®Google Scholar
• Sheridan W. P., Wolf M., Lusk J., Layton J. E., Souza L., Morstyn G., Dodds A., Maher D., Green M. D., Fox R. M. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 1989; 2: 891–894
   PubMed Web of Science ®Google Scholar
• Nemunaitis J., Rabinowe S. N., Singer J. W., Bierman P. J., Vose J. M., Freedman A. S., Onetto N., Gillis S., Oette D., Gold M., Buckner D., Hansen L. A., Ritz J., Appelbaum F. R., Armitage J. O., Nadler L. M. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N. Engl. J. Med. 1991; 324: 1773–1778
   PubMed Web of Science ®Google Scholar
• Nemunaitis J., Singer J. W., Buckner C. D., Hill R., Storb R., Thomas E. D., Appelbaum F. R. Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies. Blood 1988; 72: 834–836
   PubMed Web of Science ®Google Scholar
• Yamada M., Wassermann R., Lange B., Reichard B. A., Womer R. B., Rovera G. Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatment. N. Engl. J. Med. 1990; 323: 448–455
   PubMed Web of Science ®Google Scholar
• Wassermann R., Galili N., Ito Y., Silber J. H., Reichard B. A., Shane S., Womer R. B., Lange B., Rovera G. Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia. J. Clin. Oncol. 1992; 10: 1879–1888
   PubMed Web of Science ®Google Scholar
• Jenkins C. S. P., Ozer H., Parker J. C. Mobilization of calla-positive lymphoblasts during treatment with granulocyte colony-stimulating factor. Blood 1992; 80: 2944
   PubMed Web of Science ®Google Scholar